Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.09M Buy
128,183
+9,162
+8% +$240K 0.09% 153
2026
Q1
$3.34M Buy
119,021
+1,223
+1% +$32.6K 0.12% 123
2025
Q4
$2.93M Buy
117,798
+1,112
+1% +$28K 0.1% 138
2025
Q3
$2.97M Buy
116,686
+16,926
+17% +$418K 0.1% 133
2025
Q2
$2.42M Buy
99,760
+19,852
+25% +$463K 0.09% 157
2025
Q1
$2.02M Sell
79,908
-17,136
-18% -$448K 0.08% 173
2024
Q4
$2.57M Sell
97,044
-28,238
-23% -$766K 0.1% 145
2024
Q3
$3.63M Buy
125,282
+9,188
+8% +$268K 0.14% 110
2024
Q2
$3.25M Buy
116,094
+5,875
+5% +$162K 0.13% 114
2024
Q1
$3.06M Sell
110,219
-63,020
-36% -$1.75M 0.13% 128
2023
Q4
$4.99M Sell
173,239
-3,000
-2% -$90.7K 0.22% 70
2023
Q3
$5.85M Buy
176,239
+7,991
+5% +$283K 0.29% 64
2023
Q2
$6.17M Buy
168,248
+7,182
+4% +$280K 0.3% 61
2023
Q1
$6.57M Buy
161,066
+20,894
+15% +$902K 0.34% 54
2022
Q4
$7.18M Buy
140,172
+4,151
+3% +$199K 0.4% 47
2022
Q3
$5.95M Buy
136,021
+3,504
+3% +$170K 0.36% 52
2022
Q2
$6.95M Sell
132,517
-7,980
-6% -$407K 0.39% 46
2022
Q1
$7.27M Sell
140,497
-4,231
-3% -$220K 0.34% 52
2021
Q4
$8.55M Sell
144,728
-23,407
-14% -$1.16M 0.38% 48
2021
Q3
$7.23M Sell
168,135
-12,506
-7% -$554K 0.34% 52
2021
Q2
$7.07M Buy
180,641
+8,119
+5% +$316K 0.33% 56
2021
Q1
$6.25M Buy
172,522
+1,190
+0.7% +$42.3K 0.32% 61
2020
Q4
$6.31M Sell
171,332
-12,886
-7% -$473K 0.34% 58
2020
Q3
$6.41M Buy
184,218
+10,750
+6% +$377K 0.39% 54
2020
Q2
$5.38M Sell
173,468
-3,635
-2% -$123K 0.36% 57
2020
Q1
$5.48M Buy
177,103
+2,396
+1% +$81.6K 0.44% 51
2019
Q4
$6.49M Buy
174,707
+42,644
+32% +$1.52M 0.4% 52
2019
Q3
$4.5M Buy
132,063
+53,731
+69% +$1.95M 0.31% 65
2019
Q2
$3.22M Buy
78,332
+2,701
+4% +$107K 0.22% 86
2019
Q1
$3.05M Sell
75,631
-5,106
-6% -$204K 0.21% 94
2018
Q4
$3.34M Sell
80,737
-17,299
-18% -$718K 0.27% 78
2018
Q3
$4.1M Buy
98,036
+13,111
+15% +$505K 0.27% 72
2018
Q2
$2.92M Buy
84,925
+23,143
+37% +$791K 0.2% 93
2018
Q1
$2.08M Buy
61,782
+2,738
+5% +$94.1K 0.15% 117
2017
Q4
$2.03M Buy
59,044
+728
+1% +$24.8K 0.14% 123
2017
Q3
$1.98M Sell
58,316
-410
-0.7% -$13.2K 0.15% 113
2017
Q2
$1.87M Buy
58,726
+11,972
+26% +$378K 0.15% 112
2017
Q1
$1.52M Buy
46,754
+2,054
+5% +$64.8K 0.12% 126
2016
Q4
$1.38M Buy
44,700
+9,218
+26% +$281K 0.12% 135
2016
Q3
$1.14M Sell
35,482
-753
-2% -$25.2K 0.11% 145
2016
Q2
$1.21M Sell
36,235
-24
-0.1% -$766 0.12% 138
2016
Q1
$1.02M Buy
36,259
+318
+0.9% +$9.08K 0.1% 152
2015
Q4
$1.1M Buy
35,941
+7,364
+26% +$232K 0.11% 148
2015
Q3
$851K Buy
28,577
+1,533
+6% +$49.2K 0.1% 158
2015
Q2
$861K Sell
27,044
-245
-0.9% -$7.99K 0.09% 170
2015
Q1
$900K Buy
27,289
+599
+2% +$19K 0.1% 163
2014
Q4
$789K Sell
26,690
-1,237
-4% -$35.5K 0.09% 164
2014
Q3
$784K Sell
27,927
-5,864
-17% -$165K 0.09% 164
2014
Q2
$951K Buy
33,791
+79
+0.2% +$2.25K 0.11% 154
2014
Q1
$1.03M Sell
33,712
-1,505
-4% -$44.9K 0.12% 137
2013
Q4
$1.02M Sell
35,217
-696
-2% -$20.3K 0.12% 137
2013
Q3
$979K Buy
35,913
+805
+2% +$21.9K 0.12% 138
2013
Q2
$933K Buy
+35,108
New +$970K 0.12% 136

Other funds holding PFE

Fulton Bank's PFE Position: Q2 2026 in Review

Fulton Bank increased its Pfizer (PFE) stake by 7.7% in Q2 2026, buying an estimated $240K and bringing the position to 128,183 shares worth $3.09M. The position accounts for 0.09% of the portfolio, ranked #153.

Fulton Bank first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.55M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Fulton Bank held 128,183 shares of Pfizer worth $3.09M as of Q2 2026.
  • Fulton Bank bought 9,162 Pfizer shares in Q2 2026, an estimated $240K.
  • Pfizer made up 0.09% of Fulton Bank's portfolio in Q2 2026, its #153 holding.
  • Fulton Bank first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Fulton Bank's Pfizer position peaked at $8.55M in Q4 2021.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Fulton Bank's 13F filing for Q2 2026, filed 9 Jul 2026.